All Consumer health articles
-
NewsTesting extends range of US chocolate foods containing lead and cadmium
Consumer Reports calls on brands to do more to lower levels of metals in their products
-
BusinessUS regulator says phenylephrine is ineffective as a decongestant
FDA will begin consultation on removing the drug from hundreds of over-the-counter remedies
-
BusinessContaminated cough syrups death toll passes 300 in four months
Deadly glycol contamination discovered in Uzbekistan, following cases in The Gambia and Indonesia
-
BusinessHaleon emerges from GSK consumer healthcare spin-off
Split illustrates move towards narrower focus in pharmaceuticals
-
BusinessGSK and Pfizer joint venture creates new consumer healthcare giant
Enlarged GSK consumer health will have largest market share of any firm and be a leader in key countries
-
BusinessJ&J and the question of shadow research
Former academic researcher who found that talc is not carcinogenic admits that J&J funded his work, but says that fact is immaterial
-
BusinessJudges overturn J&J talc cancer claims
Two new rulings follow trend of reversing large jury-awarded damages as firm works through thousands of cases
-
BusinessTeva to sell off women’s health businesses for $1.4bn
Deals continue Teva’s bid to get rid of non-core businesses and raise cash to service its debts
-
BusinessTakeda tightens focus on core areas with multiple deals
Japanese firm is remodelling its R&D efforts through collaboration and licensing deals, and selling off non-core businesses
-
BusinessReckitt Benckiser to buy into baby milk
$17bn acquisition of Mead Johnson expands presence in developing markets, especially China
-
NewsEuropean regulator to look into tattoo inks
European Chemicals Agency may recommend an EU-wide ban on harmful ink components
-
BusinessSanofi and Boehringer agree €11bn asset swap
Deal swaps Sanofi’s animal health arm for Boehringer’s consumer healthcare business as both firms aim to boost scale
-
BusinessJ&J to buy Vogue for haircare range
$3.3bn deal expands Johnson & Johnson’s consumer products segment
-
ResearchFlushing advice is flawed
Protocols to restore contaminated water supplies are not based on science
-
BusinessBayer wins race to buy Merck & Co consumer care
$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company
-
Business$25bn-plus trade sharpens pharma giants’ focus
Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process
-
Business
BMS sells OTC drugs for $482m
Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
-
Business
GSK expands in India and Nigeria
Company has struck deals to increase ownership of subsidiaries
-
Business
Pfizer to pay $250m for Nexium
AstraZeneca has sold rights to an over the counter version of its heartburn tablets